ClinVar Miner

Submissions for variant NM_000143.4(FH):c.648T>A (p.Asp216Glu)

gnomAD frequency: 0.00001  dbSNP: rs199536615
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000564564 SCV000673353 benign Hereditary cancer-predisposing syndrome 2023-11-16 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Labcorp Genetics (formerly Invitae), Labcorp RCV001529212 SCV000834540 likely benign not provided 2025-01-20 criteria provided, single submitter clinical testing
GeneDx RCV001529212 SCV001764533 uncertain significance not provided 2024-10-21 criteria provided, single submitter clinical testing In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Genetic Services Laboratory, University of Chicago RCV001821687 SCV002067544 uncertain significance not specified 2018-10-25 criteria provided, single submitter clinical testing
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital RCV001821687 SCV004243528 uncertain significance not specified 2025-03-04 criteria provided, single submitter clinical testing
Myriad Genetics, Inc. RCV005248291 SCV005896455 likely benign Hereditary leiomyomatosis and renal cell cancer 2024-10-18 criteria provided, single submitter clinical testing This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance.
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV001529212 SCV001742293 likely benign not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV001529212 SCV001807472 likely benign not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV001529212 SCV001953236 likely benign not provided no assertion criteria provided clinical testing
Natera, Inc. RCV000705539 SCV002085856 uncertain significance Fumarase deficiency 2020-08-12 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.